Scurvy may be making a comeback amid economic strain

The scourge of scurvy, which is caused by vitamin C deficiency, may be re-emerging amid the cost of living crisis and the rise in weight loss (bariatric) surgery, suggest doctors in the journal BMJ Case Reports after treating a middle-aged man with the condition.

New collaboration launched to support the development of vaccines against henipavirus

A new collaboration between the UK Health Security Agency (UKHSA) and The Pirbright Institute has been launched to support the development of vaccines against henipavirus

March 13, 2024

Janssen looks to turn PhIII win for Rybrevant in EGFR-mutated NSCLC into pressure on AstraZeneca blockbuster

Johnson & Johnson’s Janssen said Wednesday that its bispecific antibody Rybrevant (amivantamab-vmjw) in combo with lazertinib met its dual primary endpoints in a Phase III

September 7, 2023

P-BCMA-ALLO1 by F. Hoffmann-La Roche for Relapsed Multiple Myeloma: Likelihood of Approval – Pharmaceutical Technology

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

October 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.